Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Asieris Pharmaceuticals
company
About
Asieris Pharmaceuticals is a Chinese biotech company.
- 101 - 250
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- ¥700M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Asieris Pharmaceuticals is a Chinese biotech company focusing on therapeutic areas in oncology and multidrug-resistant infections.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥1.09B
Asieris Pharmaceuticals has raised a total of
¥1.09B
in funding over 2 rounds. Their latest funding was raised on
Nov 11, 2020 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 11, 2020 | Series D | ¥700M | 3 | — | — | Detail |
| Jun 28, 2020 | Series C | ¥290M | 1 | — | — | Detail |
| Dec 29, 2017 | Series B | ¥100M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
5
Asieris Pharmaceuticals is funded by 5 investors.
Haoshuo Zhier Fund
and IFSC
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
IFSC
|
— | Series D |
Homsun Capital
|
— | Series D |
|
|
— | Series C |
Phoenix Fund
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
